Haemonetics CorporationStock Price and Value Analysis

Should you buy Haemonetics Corporation stock? (NYSE:HAE). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company has stable growth.
  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company pays no dividend.

HAE Free Cash Flow Trend

Based on historical returns, we believe that Haemonetics Corporation can grow its free cash at a rate of about 2%. That's positive!

Free Cash Flow trendline for HAE
Free Cash Flow trendline for Haemonetics Corporation

Inside the HAE Numbers

HAE Price
(Haemonetics Corporation stock price per share)
$56.48
[?] HAE Fair Price
(based on intrinsic value)
$25.20
[?] HAE Safety Price (based on a variable margin of safety) $16.38
[?] PE Ratio versus Sector 3140% higher than other Healthcare stocks
[?] PE Ratio versus Industry 2625% higher than other Medical Instruments & Supplies stocks
[?] Cash Yield 3.09%
[?] Free Cash Flow Jitter 22%

Is Haemonetics Corporation Stock on Sale?

We believe that Haemonetics Corporation may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Haemonetics Corporation looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy HAE Stock?

Does Haemonetics Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.